Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation - Results of a prospective study

被引:62
|
作者
Tschuschke, V
Hertenstein, B
Arnold, R
Bunjes, D
Denzinger, R
Kaechele, H
机构
[1] Univ Cologne, Dept Med Psychol Psychosomat & Psychotherapy, D-50924 Cologne, Germany
[2] Leibniz Univ Hannover, Dept Hematol Oncol, Hannover, Germany
[3] Univ Berlin, Med Clin II, Dept Hematol Oncol, Charite, Berlin, Germany
[4] Univ Ulm, Med Clin 2, Dept Internal Med 3, Ulm, Germany
[5] Univ Ulm, Dept Psychotherapy & Psychosomat, Ulm, Germany
关键词
leukemia; bone marrow transplantation; coping; fighting spirit; cancer survival; cancer progression;
D O I
10.1016/S0022-3999(01)00202-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: To investigate associations between coping strategies and length of survival in a sample of 52 adult leukemia patients receiving allogeneic bone marrow transplantation (BMT). Methods: 52 adult patients, diagnosed with acute (AML) and chronic myeloid leukemia (CML) admitted for allogeneic BMT to a university hospital BMT unit in preparation for a transplantation of genotypically matched HLA donor marrow, were interviewed immediately after informed consent and prior to preparatory treatment for transplantation. Semistructured interviews were conducted and recorded for analysis to assess coping styles and were evaluated by a new content analytic coping measure [Ulm Coping Manual (UCM)]. Patients were a random sample of all eligible patients on the BMT unit between May 1990 and May 1994. Results: Complete audiotaped interviews were rated by blind raters, employing a newly developed content analysis for the identification of patients' coping strategies. Multivariate analysis using a Cox model revealed three pretransplant variables that demonstrated a statistically significant influence on 5-year survival: Stage of Disease at transplant (P < .012), Distraction (P < .007), and Fighting Spirit as coping modalities (P < .013). Conclusions: The results of this prospective study document the impact of certain psychological variables, notably coping style on survival with BMT. This suggests the necessity of utilizing psychosocial interventions to address stress and anxiety in patients awaiting transplantation in order to reduce anxieties and to employ more effective coping techniques to deal more appropriately with their situation and to enhance Fighting Spirit. The effects on survival of such psychosocial interventions need to be tested in a randomized controlled study. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [41] Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A
    Fukuda, H
    Teshima, H
    Karasuno, T
    Hiraoka, A
    Nakamura, H
    Masaoka, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 71 (01) : 70 - 74
  • [42] Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation - a case study
    Barbaric, D
    Wynne, K
    Aslanian, S
    Bond, M
    Reid, GSD
    LEUKEMIA RESEARCH, 2005, 29 (06) : 711 - 714
  • [43] Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling
    Singhal, S
    Powles, R
    Treleaven, J
    Kulkarni, S
    Horton, C
    Mehta, J
    LEUKEMIA & LYMPHOMA, 1999, 34 (3-4) : 287 - 294
  • [44] Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study
    S Bregante
    S Bertilson
    E Tedone
    MT Van Lint
    G Trespi
    N Mordini
    G Berisso
    F Gualandi
    T Lamparelli
    O Figari
    F Benvenuto
    AM Raiola
    A Bacigalupo
    Bone Marrow Transplantation, 2000, 26 : 23 - 29
  • [45] Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study
    Bregante, S
    Bertilson, S
    Tedone, E
    Van Lint, MT
    Trespi, G
    Mordini, N
    Berisso, G
    Gualandi, F
    Lamparelli, T
    Figari, O
    Benvenuto, F
    Raiola, AM
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2000, 26 (01) : 23 - 29
  • [46] Multiple bone lesions after allogeneic bone marrow transplantation in a patient with relapsed adult acute lymphoblastic leukemia: Minimal residual disease analysis may predict extramedullary relapse
    Nomura, K
    Okamoto, T
    Nakao, M
    Ueda, K
    Akano, Y
    Fujita, Y
    Kobayashi, M
    Yokota, S
    Horiike, S
    Nishida, K
    Kusuzaki, K
    Taniwaki, M
    LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1305 - 1308
  • [47] Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients
    Quaglino, P.
    Nardo, T.
    Fierro, M. T.
    Massaia, M.
    Orsucci, L.
    Fava, P.
    Marenco, F.
    Marra, E.
    Savoia, P.
    Vitolo, U.
    Boccadoro, M.
    Bernengo, M. G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2013, 148 (05): : 453 - 463
  • [48] High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study
    Vannucchi, AM
    Bosi, A
    Linari, S
    Guidi, S
    Longo, G
    Lombardini, L
    Mariani, MP
    Saccardi, R
    Laszlo, D
    Ferrini, PR
    HAEMATOLOGICA, 1997, 82 (01) : 53 - 56
  • [49] Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)
    Michel, G
    Baruchel, A
    Tabone, MD
    Nelken, B
    Leblanc, T
    Thuret, I
    Bordigoni, P
    Bergeron, C
    EsperouBourdeau, H
    Perel, Y
    Vannier, JP
    DeLumley, L
    Dommergues, JP
    Lamagnere, JP
    Couillaud, G
    Auvrignon, A
    Schaison, G
    Leverger, G
    HEMATOLOGY AND CELL THERAPY, 1996, 38 (02) : 169 - 176
  • [50] SECRETION OF LEUKEMIA INHIBITORY FACTOR AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A STUDY OF CD4(+) AND CD8(+) TCR-ALPHA-BETA(+) T-CELL CLONES DERIVED FROM 4 LEUKEMIA PATIENTS
    BRUSERUD, O
    HAMANN, W
    PAWELEC, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (02) : 106 - 110